Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 1,420.90
+8.40 (0.59%)
Apr 24, 2025, 3:30 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 398.59 billion as of April 24, 2025. Its market cap has increased by 43.11% in one year.
Market Cap
398.59B
Enterprise Value
398.20B
Revenue
139.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,420.90
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 398.59B, an increase of 34,581.08%. That is a compound annual growth rate of 27.74%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,192.60B |
| Divi's Laboratories | 1,569.32B |
| Cipla | 1,234.20B |
| Mankind Pharma | 1,064.25B |
| Apollo Hospitals Enterprise | 1,019.22B |
| Zydus Lifesciences | 858.02B |
| Aurobindo Pharma | 689.82B |
| Alkem Laboratories | 599.45B |